<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Urea (systemic): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Urea (systemic): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Urea (systemic): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="110978" href="/d/html/110978.html" rel="external">see "Urea (systemic): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F49189796"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ure-Na</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F49189798"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Medical Food</li></ul></div>
<div class="block doa drugH1Div" id="F49411765"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="08e11669-2dba-4f34-ae69-47cb35818936">Syndrome of inappropriate antidiuretic hormone secretion–associated hyponatremia, treatment and/or maintenance therapy</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Syndrome of inappropriate antidiuretic hormone secretion–associated hyponatremia, treatment and/or maintenance therapy:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b> May consider in patients who do not respond to fluid restriction or are unable to be fluid restricted, or to maintain serum sodium level after successful treatment of symptomatic hyponatremia (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30614552','lexi-content-ref-Sterns.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30614552','lexi-content-ref-Sterns.2'])">Ref</a></span>). Goal of initial therapy is to achieve a 24-hour increase in serum sodium concentration by 4 to 6 mEq/L (maximum serum sodium increase: 8 mEq/L in any 24-hour period), which is sufficient to improve most symptoms of hyponatremia. However, if patient is symptomatic (acute or chronic hyponatremia), it is recommended to increase serum sodium by 4 to 6 mEq/L within the first 6 hours, then maintain serum sodium at a constant level for the remainder of the 24-hour period. In chronic severe hyponatremia, overcorrection or too rapid correction increases the risk of iatrogenic osmotic demyelination syndrome (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sterns.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sterns.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> Initial: 15 to 30 g daily in 1 or 2 divided doses; titrate dose based on clinical response in increments of 15 g at weekly intervals; maximum daily dose: 60 g/day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30614552','lexi-content-ref-30868608','lexi-content-ref-31851974','lexi-content-ref-22403276','lexi-content-ref-24074529']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30614552','lexi-content-ref-30868608','lexi-content-ref-31851974','lexi-content-ref-22403276','lexi-content-ref-24074529'])">Ref</a></span>). For treatment goals, refer to "Note."</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991895"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50989067"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F49411766"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F49335940"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Endocrine &amp; metabolic: Hypernatremia</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Mildly upset stomach</p></div>
<div class="block coi drugH1Div" id="F49189801"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer’s labeling.</p></div>
<div class="block foc drugH1Div" id="F49210019"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Powder for Solution, Oral:</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ure-Na: 15 g (8s) [lemon-lime flavor]</p></div>
<div class="block adm drugH1Div" id="F49411770"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Mix each 15 g dose with 3 to 4 ounces of water or juice.</p></div>
<div class="block use drugH1Div" id="F49189800"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Syndrome of inappropriate antidiuretic hormone secretion–associated hyponatremia, treatment and/or maintenance therapy: </b>A medical food for the management of hyponatremia (euvolemic and hypervolemic).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note:</b> A medical food is formulated to be administered enterally under the supervision of a physician and is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements are established by medical evaluation. Medical foods are not drugs and, therefore, are not subject to any FDA regulatory requirements that specifically apply to drugs (eg, requirement for written/oral prescription prior to dispensing, premarket review or approval, proof of safety and efficacy).</p></div>
<div class="block mst drugH1Div" id="F55730870"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:0em;margin-left:2em;margin-right:4em;margin-top:0em;">Ure-Na may be confused with hydroxyurea</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F49411789"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F49411786"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block mop drugH1Div" id="F49411772"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Serum sodium</p></div>
<div class="block pha drugH1Div" id="F49411764"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Urea normalizes serum sodium levels by inducing osmotic excretion of free water. Urea also ameliorates hyponatremia in syndrome of inappropriate antidiuretic hormone secretion by a more specific effect, diminishing the natriuresis in association with increased medullary urea content.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58213651"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Urea nm</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Ure na</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Urea nm</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-ACMP.1">
<a name="ACMP.1"></a>ACMP Dossier: Ure-Na. Phoenix, AZ: Nephcentric; received November 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30614552">
<a name="30614552"></a>Lockett J, Berkman KE, Dimeski G, Russell AW, Inder WJ. Urea treatment in fluid restriction-refractory hyponatraemia. <i>Clin Endocrinol (Oxf)</i>. 2019;90(4):630-636. doi:10.1111/cen.13930<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/urea-systemic-drug-information/abstract-text/30614552/pubmed" id="30614552" target="_blank">30614552</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30868608">
<a name="30868608"></a>Nervo A, D'Angelo V, Rosso D, et al. Urea in cancer patients with chronic SIAD-induced hyponatremia: old drug, new evidence. <i>Clin Endocrinol (Oxf)</i>. 2019;90(6):842-848. doi:10.1111/cen.13966<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/urea-systemic-drug-information/abstract-text/30868608/pubmed" id="30868608" target="_blank">30868608</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31851974">
<a name="31851974"></a>Rondon-Berrios H. Urea for chronic hyponatremia. <i>Blood Purif</i>. 2020;49(1-2):212-218. doi:10.1159/000503773<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/urea-systemic-drug-information/abstract-text/31851974/pubmed" id="31851974" target="_blank">31851974</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22403276">
<a name="22403276"></a>Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. <i>Clin J Am Soc Nephrol</i>. 2012;7(5):742-747. doi:10.2215/CJN.06990711<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/urea-systemic-drug-information/abstract-text/22403276/pubmed" id="22403276" target="_blank">22403276</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Sterns.1">
<a name="Sterns.1"></a>Sterns RH. Overview of the treatment of hyponatremia in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed October 4, 2021a.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Sterns.2">
<a name="Sterns.2"></a>Sterns RH. Treatment of hyponatremia: syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed October 4, 2021b.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24074529">
<a name="24074529"></a>Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. <i>Am J Med</i>. 2013;126(10)(suppl 1):S1-S42. doi:10.1016/j.amjmed.2013.07.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/urea-systemic-drug-information/abstract-text/24074529/pubmed" id="24074529" target="_blank">24074529</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 110864 Version 25.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
